{"nct_id":"NCT04268771","title":"A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products","status":"COMPLETED","status_verified_date":"2023-10","start_date":"2020-04-08","start_date_type":"ACTUAL","primary_completion_date":"2022-01-26","primary_completion_date_type":"ACTUAL","completion_date":"2022-04-20","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["RDY"]}